Robert W. Postma - Sep 2, 2021 Form 4 Insider Report for ZIOPHARM ONCOLOGY INC (TCRT)

Role
Director
Signature
/s/ Courtney Thorne, Attorney-in-Fact
Stock symbol
TCRT
Transactions as of
Sep 2, 2021
Transactions value $
$129,750
Form type
4
Date filed
9/3/2021, 05:22 PM
Next filing
Jun 24, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TCRT Common Stock Purchase $35.5K +20.5K +1.74% $1.73* 1.2M Sep 2, 2021 Direct F1
transaction TCRT Common Stock Purchase $94.3K +54.5K +1.3% $1.73* 4.25M Sep 2, 2021 See footnote F2
holding TCRT Common Stock 3.57K Sep 2, 2021 By Spouse's IRA
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 946,970 shares of common stock underlying the Units. The Reporting Person purchased 946,970 units of the Issuer (the "Units") for $2.64 per Unit in a private placement transaction with the Issuer. Each Unit consists of one share of common stock and a warrant to acquire one share of common stock.
F2 The shares are directly held by WaterMill Asset Management Corp. ("WaterMill"). The Reporting Person serves as the principal of WaterMill.